Photo: Jhpiego
Since 1997, we have worked in these technical areas:
Family Planning and Reproductive Health
Maternal, Newborn and Child Health
Infection Prevention and Control
Digital Health
The U.S. Agency for International Development’s Bureau for Global Health’s flagship Maternal and Child Survival Program (MCSP) focuses on 25 high-priority countries with the ultimate goal of preventing child and maternal deaths. MCSP is introducing and supporting high-impact, sustainable reproductive, maternal, newborn and child health (RMNCH) interventions in partnership with ministries of health and other partners. In addition to contributing to high-level technical and policy dialogue at the global level, MCSP provides tailored technical assistance to help countries meet specific priorities and contextual needs of local, sustainable RMNCH programs. For information on what MCSP is doing in this country, visit here: http://www.mcsprogram.org/where-we-work/pakistan/.
Funded by the Bill & Melinda Gates Foundation, the David and Lucile Packard Foundation, and the Aman Foundation, the four-year Sukh Initiative has the goal of contributing to a 15% increase in the contraceptive prevalence rate for modern methods of family planning (FP) across a population of approximately one million people in Karachi. Building on momentum from national and international donors, and the Government of Pakistan’s desire to expand access to high-quality FP in Karachi’s growing urban population, Jhpiego is preparing public-sector stakeholders, including maternity homes and clinics, to offer a range of modern FP services, as well as high-quality postpartum FP and postabortion care/postabortion FP.
With funding from Gavi, the Vaccine Alliance, Jhpiego is working in Pakistan on a national introduction of a human papillomavirus (HPV) vaccine. With the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health as a partner, Jhpiego is providing technical assistance to: 1) draft a road map for preparing Pakistan to consider HPV vaccine introduction, 2) bridge gaps in knowledge and understanding of cervical cancer prevention and control, 3) make the investment case for bundling of services to address health for every woman and girl, and 4) support country partners, an HPV working group and HPV champions by providing a secretarial and administrative platform for engagement activities.
The U.S. Agency for International Development’s Bureau for Global Health’s flagship Maternal and Child Survival Program (MCSP) focuses on 25 high-priority countries with the ultimate goal of preventing child and maternal deaths. MCSP is introducing and supporting high-impact, sustainable reproductive, maternal, newborn and child health (RMNCH) interventions in partnership with ministries of health and other partners. In addition to contributing to high-level technical and policy dialogue at the global level, MCSP provides tailored technical assistance to help countries meet specific priorities and contextual needs of local, sustainable RMNCH programs. For information on what MCSP is doing in this country, visit here: http://www.mcsprogram.org/where-we-work/pakistan/.
Funded by the Bill & Melinda Gates Foundation, the David and Lucile Packard Foundation, and the Aman Foundation, the four-year Sukh Initiative has the goal of contributing to a 15% increase in the contraceptive prevalence rate for modern methods of family planning (FP) across a population of approximately one million people in Karachi. Building on momentum from national and international donors, and the Government of Pakistan’s desire to expand access to high-quality FP in Karachi’s growing urban population, Jhpiego is preparing public-sector stakeholders, including maternity homes and clinics, to offer a range of modern FP services, as well as high-quality postpartum FP and postabortion care/postabortion FP.
With funding from Gavi, the Vaccine Alliance, Jhpiego is working in Pakistan on a national introduction of a human papillomavirus (HPV) vaccine. With the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health as a partner, Jhpiego is providing technical assistance to: 1) draft a road map for preparing Pakistan to consider HPV vaccine introduction, 2) bridge gaps in knowledge and understanding of cervical cancer prevention and control, 3) make the investment case for bundling of services to address health for every woman and girl, and 4) support country partners, an HPV working group and HPV champions by providing a secretarial and administrative platform for engagement activities.